News Search

Topics

View All Topics

Showing 981 - 990 of 7170 results.

Logan Paul’s Prime Energy Drink Under Scrutiny Over High Caffeine Content

Source:

The New York Times

July 12, 2023

Dr. Edith Bracho-Sanchez wrote in an email that regularly consuming as much caffeine as is found in Prime Energy can disrupt the sleep cycle, which is essential to a child’s developing brain.
CUIMC Update - July 12, 2023

July 12, 2023

View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.

Topic

Campus News
Could Drops Replace Eye Injections for Retina Disease?

July 12, 2023

A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.

Topic

Ophthalmology
Students at the Bench

July 12, 2023

Each year, several medical students work for 12 months as dean’s research fellows. An increase in applications shows more students are interested in learning the fundamental tools of research.

Topic

Education
VP&S Afternoon of Science Series Kicks Off

July 11, 2023

Afternoons of Science at VP&S offer a chance for basic science departments and institutes to share their latest research and vision for the future.

Topic

Campus News
Can you hydrate with energy drinks?

July 11, 2023

Being hydrated is important to our health, but energy and hydration drinks often come with other costs.

Topic

Nutrition
40 Years of Fertility Treatment at Columbia: Then and Now

July 11, 2023

As Columbia University Fertility Center celebrates its 40th anniversary, look back at how fertility treatment has evolved during that time.

Topic

Campus News
How Heart Failure Leads to Cognitive Decline

July 10, 2023

Heart failure may lead to cognitive decline by creating a tiny calcium leak inside the brain’s neurons.

Topic

Heart Health
Depersonalization: Everything You Need to Know

July 10, 2023

Dr. Jacques Ambrose describes the symptoms and treatments for depersonalization disorder in the wake of recent news about "SNL" cast member Bowen Yang.

Topic

Mental Health
What to Know About the Newest Approved Drug for Alzheimer's

July 8, 2023

Lecanemab, marketed as Leqembi, is the first drug for Alzheimer’s disease to receive approval on the basis of clinically slowing the progression of Alzheimer’s disease.

Topic

Neurology

News Search

Topics

Source:

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Pages